Thermo Fisher 'Ruthlessly' Focused on Winning in Mass-Spec Space, CEO Tells Investors | GenomeWeb

By Tony Fong

Thermo Fisher Scientific's chief executive, speaking at the annual JP Morgan Healthcare Conference this week, challenged his competitors in the mass-spec space to better his company's technology and to capture more market share, and said Danaher's recent entry into the market is a non-factor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.